Construction of a Prognostic Model for KIRC and Identification of Drugs Sensitive to Therapies - A Comprehensive Biological Analysis Based on m6A-Related LncRNAs.

Xia, Dian; Liu, Qi; Yan, Songbai; Bi, Liangkuan

Xia, Dian; Liu, Qi; Yan, Songbai; Bi, Liangkuan.

Afiliación

Xia D; Department of Urology, The Second Hospital of Anhui Medical University, Hefei, China.
Liu Q; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yan S; Department of Urology, The Second Hospital of Anhui Medical University, Hefei, China.
Bi L; Department of Urology, The Second Hospital of Anhui Medical University, Hefei, China.

Front Oncol ; 12: 895315, 2022.

Article en En | MEDLINE | ID: mdl-35719976

Palabras clave

LncRNA; bioinformatics; immune response; kidney renal clear cell carcinoma; m6A; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google